Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02619968
Other study ID # 07587234403
Secondary ID
Status Not yet recruiting
Phase N/A
First received November 30, 2015
Last updated November 30, 2015
Start date January 2016
Est. completion date March 2017

Study information

Verified date November 2015
Source Universidade Federal de Pernambuco
Contact Jefferson B Barbosa, physiotherapist
Phone 55 21268496
Email jbnunesfisio@gmail.com
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Interventional

Clinical Trial Summary

The aim of this study is to analyze the effectiveness of physical exercise with blood flow restriction on the diameter and the flow of vessels, muscle strength and circumference of the forearm in patients with CKD prior to making FAV.


Description:

Definitions of goals

General Analyze the effectiveness of physical exercise with blood flow restriction on the diameter and the flow of vessels, muscle strength and circumference of the forearm in patients with CKD prior to making arteriovenous fistula.

Specific

- Draw the profile of patients with CKD as the clinical and laboratory features (hematocrit, hemoglobin, urea, creatinine) and glomerular filtration rate;

- Assess the vascular conditions, muscle strength and circumference of the upper limb of the non-dominant forearm before and after exercise programs;

- Compare the physical exercise programs with and without blood flow restriction vascular changes, muscle strength and circumference of the non-dominant arm;

- To correlate the diameter measurements and blood flow to the muscle strength and circumference of the upper limb not dominant.

Methodology Study design This is a randomized controlled trial, blind and endowed with allocation concealment to be developed in Physiotherapy clinic and Nephrology at the Clinical Hospital, Federal University of Pernambuco and Cardiopulmonary Physiotherapy Laboratory in the Department of Physical Therapy, Federal University of Pernambuco, the From December 2015 to November 2016, following approval of the Committee of Ethics in Research / the Health Sciences Center.

After approval by Committee of Ethics in Research / the Health Sciences Center according to Resolution 466/2012 of the National Health Council and the explanation of the study, participants will be asked to sign the Informed Consent (IC).

The recruitment and evaluations will be carried out by a single evaluator, who will be blinded when randomization, allocation and interventions.

Inclusion criteria The sample will consist of patients with Chronic Kidney Disease (CKD) Stage 4 or 5, of both sexes, from 18 years of age, in conservative or dialysis treatment with medical indication of arteriovenous fistula as an achievement of hemodialysis.

Exclusion criteria Are excluded those that present cognitive impairment or changes that hinder understanding, realization of activities and interpretation of the issues; a history of making arteriovenous fistula in both upper limbs or some other type of vascular surgery in upper limbs, with some type of vascular access in upper limbs or in nearby regions; to develop some kind of manual work with heavy loads; Trauma-orthopedic lesions in the cervical, shoulder, elbow, wrist and untreated (or) hand; signs of thrombophlebitis and hypoplasia / agenesis of the upper limbs.

Study design After enrollment in the nephrology clinic of the Clinical Hospital / Federal University of Pernambuco will initially applied the Mini-Mental State Examination (MMSE), to exclude the possibility of cognitive impairment.

Anamnesis It will be performed in the clinic of Nephrology, after the MMSE through questionnaire with open and closed questions. The data used are: sex, age (years), weight (kg), height (m), body mass index (BMI), blood pressure (BP) (mmHg) (Brazilian Society of Cardiology, 2010), etiology and stage CKD, serum creatinine (mg / dL) and urea (mg / dL) of the last test reported in medical records and Glomerular Filtration Rate (mL / min) (Cockcroft; GAULT, 1976), hematocrit (%) and hemoglobin (g / dL) and current medications. These data will be checked in an interview and medical records of patients that will be opened during the interview will last approximately 15 minutes. After the date for physical examination will be scheduled.

Physical exam It will be held on Cardiopulmonary Physiotherapy laboratory at Federal University of Pernambuco. The patient will designate its upper limb non-domimant, according to the guidelines of the Kidney Disease Outcomes Quality Initiative Guidelines (VASCULAR ACCESS WORK GROUP, 2006). Then will take place the forearm circumference assessments, morphology of the vessels and handgrip strength. This will take the total duration of approximately 50 minutes.

Circumference forearm The circumference of the forearm will be performed by perimetry (tape nylon). The patient will be sitting in the chair with the supinated forearm and elbow flexed at 90 °. The tape is positioned at the distal 2 cm of the cubital fossa (KONG et al, 2014). Will be held 3 measurements, registering the highest value.

Morphology vessel To evaluate the radial artery are measured the internal cross-sectional diameter (mm) at flow rate of [systolic peak (cm / sec) and average velocity (cm / s)]. For the cephalic vein, will be measured basal venous outside diameter (mm) and venous outer diameter after placement of tourniquet (mm), and distensibility of the cephalic vein (%) for upper limb (UL) by ultrasonography [Sonoace R3 ( Samsung Medison - South Korea)]. A linear transducer 10 megahertz multifrequency (RUS et al, 2005; Kumar et al, 2010; RUS et al, 2005) will be used.

Handgrip strength Will be assessed by manual dynamometer (Smedley Dynamometer - Type hand mark Saehan - Korea) to evaluate the maximum voluntary contraction (MVC). Will be conducted two tests with rest interval of five minutes after the first reading, is considered the greatest value.

Evaluations of the circumference of the forearm, the vessel morphology and handgrip strength will be performed by the same evaluator before and after the interventions, which will be blinded as to the randomization of patients to interventions and their implementation (KONG et al, 2014).

Intervention Protocol Will run for eight weeks for each patient, being developed in five days of the week (2 days with supervision by the physiotherapist on an outpatient basis and 3 days at home).

After randomization, patients will be divided into two groups, experimental (EG) and control (CG).

Experimental group For experimental group, will be held isometric and isotonic concentric to the flexor muscles of the elbow and wrist using tennis ball, halter and handgrip added to partial occlusion of blood flow to tourniquet application.

Between exercise modalities will be given two minutes apart.

Partial occlusion protocol for prescription tourniquet for treatment:

Application of the tourniquet Will be held in conjunction with exercises for the experimental group group will be determined in the interview. The partial occlusion of blood flow will be induced by inflation of a tensiometer on the upper arm and the stethoscope is placed on the medial aspect of the elbow crease, (3M ™ Littmann® Classic II SE, USA) to verify the absence of the arterial pulse. After the disappearance of the sound, the cuff is deflated slowly, observing the first arterial pulse, which is used 50% of it to occlusion during training, and graduated in mmHg. This pressure will be maintained for the three types of exercises in all grades, including the 2-minute interval during periods of rest (LOENNEKE et al, 2015).

Tennis ball For exercises with tennis ball, will initially be 3 sets, where one series with 10 grips (each squeeze lasting 3 seconds, 1 second rest), increasing 5 grips every week, 60 seconds rest every series. There will be two minutes of rest, then will repeat the same sequence. After, it will be given two minutes of rest for the next activity (KONG et al, 2014).

Halter The exercises are performed with load of 1 kg (during the first two weeks of training), 2 kg (for the last two weeks of the first month) and 3 kg for the last 4 weeks. The exercise will be conducted through elbow flexion, with the patient seated. The exercise will consist of three sets of 10 movements, maintaining shrinkage for 3 seconds, followed by 1-second standing (extension member). Between each series of 10 contractions will rest 60 seconds. 2 will be given minutes of rest at the end of this, before the next activity (SALIMI et al, 2013).

Handgrip They will be performed 3 sets of dynamic manual hold exercises in the intensity of 40% of MVC, with a frequency of 20 contractions per minute (duty cycle of 2/2 of contraction and 1 second rest). After 3 sets of 20 contractions, will be given one minute of rest. This activity will be performed to volitional fatigue, and recorded the time and amount of sets performed per patient (Hunt et al, 2012; UY et al, 2013).

Home program At home will be performed isometric exercises with tennis ball on the same frequency as in performing ambulatory without applying the tensiometer. Will be held the two sequences (3 sets of 10 grips) once daily for three days this week, which will be guided verbally by the trainer and delivered all the guidelines through leaflet, materials for the exercise and a daily control conducting training. Links will be held daily to help control procedures. Appendix 6 presents the check-list for muscle training the experimental group (Hunt et al, 2012).

Group control In the control group (CG) will be held the same isometric and isotonic concentric ambulatory and home with the same duration, frequency and intensity, except is not to apply the tourniquet.

Completion of the program The program will end at the end of the 3rd day of the last week of the completion of home procedures, and scheduled the revaluation and its realization in sequence.

It will be recorded the frequency of patients to outpatient care and conducting training at home in both groups by the instructor. Patients who do not carry 75% of the program will be given as loss of tracking.

Tabulation plan and analysis Spreadsheets Data will be recorded primarily in chips assessments of each patient, and then will be transferred to the Microsoft Office Excel spreadsheets type, version 2010® and later to the software Statistical Package for the Social Sciences (SPSS) version 20.0 for Windows for statistical analysis.

Statistical methods for data analysis Initially descriptive data analysis will be carried out, which may be presented as mean ± standard deviation, confidence interval of 95% and frequency distribution. The normal distribution is used for the continuous variables, using the Shapiro-Wilk test and the homogeneity using Levene's test. At the end of the program will be realized the Student t test for paired comparing pre and post between the same groups and the Mann-Whitney test for comparisons between groups of non-paired samples. For correlations will be used the Pearson or Spearman correlation test. It will be considered p value less than 0.05 as significant. For data analysis, SPSS for Windows version 20.0 is used.

Budget - funding

Material - Cost (R $) A4 reams of paper, 75g / m² - 5 units - 50.00 Black ink cartridges for the printer - 03 units - 90.00 Color ink cartridges for printer - 02 units - 70.00 Pens - 01 box with 50 units. - 8:00 pm Test copies and instruments - 35.00 Clipboard - 7.00 Photo copies - 50.00 1 compact disk box with 10 units - 10.00 Aneroid sphygmomanometer manual Premium - 1 unit - 60.00 Handgrip with adjustable load of 5 to 20 kg - 3 units (42,00 each R $) - 126.00 Handgrip with adjustable load of 10 to 40 kg - 3 units (55,00 each R $) - 165.00 Rubberized dumbbells 1 kg - 3 units (R $ 12.90 each) - 38.70 Rubberized dumbbells 2 kg - 3 units (R $ 20.90 each) - 62.70 Rubberized dumbbells 3 kg - 3 units (R $ 29.90 each) -89.70 Tennis Balls - 54 units (R $ 6.00 each) - 324.00 Nylon tape metric - 1 unit - 5.00 Ultrasound R3 Sonoace (Samsung Medison - South Korea) * - 75,000.00 Stethoscope 3M ™ Littmann Classic II SE, USA - 420.00 Manual dynamometer (Smedley Dinamometer - Type hand mark Saehan - Korea * - 1,499.00 Total - 78122.10

* Available in the research sites. The total cost for the research project will be the responsibility of the researcher, at no cost to the institution.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date March 2017
Est. primary completion date March 2017
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Patients with Chronic Kidney Disease (CKD) stage 4 or 5;

- In conservative or dialysis treatment;

- Medical indication of arteriovenous fistula as an achievement of HD.

Exclusion Criteria:

- Cognitive impairment or changes that hinder understanding, realization of activities and interpretation of the issues;

- a history of making FAV in both upper limbs or some other type of vascular surgery in upper limbs, with some type of vascular access in upper limbs or in nearby regions;

- to develop some kind of manual work with heavy loads;

- Trauma-orthopedic lesions in the cervical, shoulder, elbow, wrist and untreated (or) hand;

- Signs of thrombophlebitis and hypoplasia / agenesis of the upper limbs.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Intervention

Other:
experimental group
Will be held isometric and isotonic concentric to the flexor muscles of the elbow and wrist using tennis ball, halter and handgrip added to partial occlusion of blood flow to tourniquet application. The Application of the tourniquet will be held in conjunction with exercises for the experimental group.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Universidade Federal de Pernambuco

References & Publications (6)

Kumar S, Seward J, Wilcox A, Torella F. Influence of muscle training on resting blood flow and forearm vessel diameter in patients with chronic renal failure. Br J Surg. 2010 Jun;97(6):835-8. doi: 10.1002/bjs.7004. — View Citation

Levey AS, Coresh J. Chronic kidney disease. Lancet. 2012 Jan 14;379(9811):165-80. doi: 10.1016/S0140-6736(11)60178-5. Epub 2011 Aug 15. Review. — View Citation

Lugon JR. End-stage renal disease and chronic kidney disease in Brazil. Ethn Dis. 2009 Spring;19(1 Suppl 1):S1-7-9. — View Citation

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266. — View Citation

Rus RR, Ponikvar R, Kenda RB, Buturovic-Ponikvar J. Effect of intermittent compression of upper arm veins on forearm vessels in patients with end-stage renal disease. Hemodial Int. 2005 Jul;9(3):275-80. — View Citation

Rus RR, Ponikvar R, Kenda RB, Buturovic-Ponikvar J. Effect of local physical training on the forearm arteries and veins in patients with end-stage renal disease. Blood Purif. 2003;21(6):389-94. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Increasing the diameter of the cephalic vein Increasing the diameter of the cephalic vein of at least 0.22 mm 8 weeks of training for each patient No
Secondary Increasing the diameter of the radial artery 8 weeks of training for each patient No
Secondary Radial artery blood flow 8 weeks of training for each patient No
Secondary Forearm Circumference 8 weeks of training for each patient No
Secondary Muscle strength of the forearm 8 weeks of training for each patient No
See also
  Status Clinical Trial Phase
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Terminated NCT04043026 - The Effects of Renal Function and Atrial Fibrillation on Lipoproteins and Clot Structure/Function
Completed NCT05318014 - Low-protein Formula Supplements in Chronic Kidney Disease N/A
Active, not recruiting NCT06071065 - Clinical Pharmacist Intervention on Medication Adherence and Clinical Outcomes in Chronic Kidney Disease Patients N/A
Completed NCT02878317 - Skin Autofluorescence as a Risk Marker in People Receiving Dialysis.
Not yet recruiting NCT06039254 - Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function Phase 1
Recruiting NCT03160326 - The QUALITY Vets Project: Muscle Quality and Kidney Disease
Completed NCT02888171 - Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency N/A
Completed NCT02836574 - A Study of Renal Autologous Cell Therapy (REACT) in Type 2 Diabetics With Chronic Kidney Disease Phase 2
Completed NCT02756520 - Observational Study on CKD Treatment With a Ketosteril Supplemented Protein-restricted Diet (Keto-024-CNI)
Withdrawn NCT02885545 - The Strategy to Prevent Hemorrhage Associated With Anticoagulation in Renal Disease Management (STOP HARM) Trial Phase 4
Completed NCT02875886 - DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease Phase 4
Completed NCT02896309 - The Effect of Correction of Metabolic Acidosis in CKD on Intrarenal RAS Activity N/A
Active, not recruiting NCT02483039 - Nephrologist Follow-up Versus Usual Care After an Acute Kidney Injury Hospitalization N/A
Completed NCT02369549 - Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease Phase 3
Terminated NCT02543177 - Optimised Procedure in Patients With NSTEMI and CKD N/A
Completed NCT02992548 - Effect of Pravastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease Phase 4
Recruiting NCT02205944 - Impact of Presurgical Exercise on Hemodialysis Fistula Outcomes N/A
Active, not recruiting NCT02231138 - Efficacy and Safety of Abelmoschus Manihot for Chronic Kidney Disease Phase 4